Cell and Gene Therapies

St Vincent's Institute of Medical Research

Cerulea Clinical Trials CERA

Responsibilities of the group include:

Advising the MACH STRaP committee and on gene, cell, and gene modified cell therapy strategy and priorities as required
Building capacity and capability in gene, cell and gene modified cell therapy development and delivery across MACH partners through:

Acting as a collaborative voice across MACH and advocating internally and externally as required
Leading activities across MACH partners in areas identified as priority
Working with other MACH networks on collaborative opportunities
Facilitating sharing of relevant knowledge and resources between MACH partners

The committee will focus activity on the following recommendations from a 2022 MACH-led scoping process:

Vale Professor Helen Thomas, an outstanding medical researcher and valued member of this network.

Name:	Affiliations:	Bio:
Dr Michelle Bradney	Cerulea Clinical Trials CERA
Dr Chaoguang Chen	CSL Ltd
Associate Professor Rachel Conyers	Royal Children's Hospital
Associate Professor Andrew Deans	St Vincent’s Institute of Medical Research
Dr Jennifer Hollands	Cerulea Clinical Trials CERA
Associate Professor Angus Johnston	Monash Institute of Pharmaceutical Sciences
Dr Conor Kearney	Olivia Newton-John Cancer Research Institute
Dr Tanya Medley	Murdoch Children's Research Institute
Dr Bev Menner	Cell Therapies Pty Ltd
Professor Shalin Naik	Walter and Eliza Hall Institute of Medical Research
Associate Professor Jane Oliaro	Peter MacCallum Cancer Centre
Professor Clare Parish	The Florey Institute
Professor Enzo Porrello	Murdoch Children's Research Institute
Professor Colin Pouton	Monash Institute of Pharmaceutical Sciences
Professor Christine Wells	The University of Melbourne